KS

Kumaran Sampath

Active Director Director DIN 08165383
DIN 08165383 First appointment Jul 2018 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 5 active board seats
Past companies 1 historical roles
Total affiliations 6 Since Jul 2018
Shareholding value •••• Premium profile

About Kumaran Sampath

Data last updated:

Kumaran Sampath is a Director at Genlabs Healthcare Private Limited (since 2025), Managing Director at Aegma Capital Services Private Limited (since 2020) and Director at Tx Primary Medicare Plus Private Limited (since 2024), and holds 2 more current directorships. The companies operate in Healthcare, Financial Services and Printing & Publishing. The 2 current companies with reported revenue have a combined latest revenue of ₹88.3 Lakh; the largest is Genlabs Healthcare Private Limited at ₹85.6 Lakh (FY 2025). Earlier, Kumaran Sampath was a Director at Olety Finance Private Limited (2018–2025).

DIN 08165383
Primary Designation Director
Industry Healthcare
First Appointment 06 Jul 2018
Oldest Company Age 12 yrs
Largest company Genlabs Healthcare Private Limited · ₹85.6 Lakh (FY 2025)
Combined revenue ₹88.3 Lakh across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Genlabs Healthcare Private Limited U85100KA2013PTC071790
Director14 Aug 20252013₹85.6 Lakh (FY 2025)Active
Managing Director08 Aug 20202020₹2.7 Lakh (FY 2024)Active
Director19 Aug 20242024Active
Director22 Apr 20242016Active
Aegma Money Mart Private Limited U66190KA2024PTC186852
Director30 Mar 20242024Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Olety Finance Private Limited U85110KA1996PTC019734
Director06 Jul 20181996₹24.2 Lakh (FY 2024)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Aegma Capital Services Private Limited
Genlabs Healthcare Private Limited
Eloquent News And Views Private Limited
Tx Primary Medicare Plus Private Limited
Premium access

Shareholding and investment profile for Kumaran Sampath

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kumaran Sampath

Kumaran Sampath currently holds 5 directorships: Genlabs Healthcare Private Limited (Director, since 14 Aug 2025, revenue ₹85.6 Lakh (FY 2025)); Aegma Capital Services Private Limited (Managing Director, since 08 Aug 2020, revenue ₹2.7 Lakh (FY 2024)); Tx Primary Medicare Plus Private Limited (Director, since 19 Aug 2024); Eloquent News And Views Private Limited (Director, since 22 Apr 2024); Aegma Money Mart Private Limited (Director, since 30 Mar 2024).

Kumaran Sampath was first appointed on 06 Jul 2018 as Director at Olety Finance Private Limited. The most recent appointment on record is 14 Aug 2025 at Genlabs Healthcare Private Limited.

The 2 current companies of Kumaran Sampath that report revenue have a combined latest revenue of ₹88.3 Lakh: Genlabs Healthcare Private Limited ₹85.6 Lakh (FY 2025); Aegma Capital Services Private Limited ₹2.7 Lakh (FY 2024).

Kumaran Sampath held 1 earlier board appointment: Olety Finance Private Limited (Director, 06 Jul 2018 to 20 Dec 2025).

The current boards of Kumaran Sampath's companies include Narayan Srinivas (Genlabs Healthcare Private Limited), Suresh Maloor Srinivasan (Genlabs Healthcare Private Limited), Kumar Thangadhorai (Aegma Capital Services Private Limited), Tarakumaran (Aegma Capital Services Private Limited), Venkatesh Vasantha Madhava (Tx Primary Medicare Plus Private Limited), Gottigere Chandrashekar Somadas (Eloquent News And Views Private Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available